{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:00Z","timestamp":1792801380315,"version":"4.5.0"},"reference-count":185,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00702-015-1405-5","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T14:32:33Z","timestamp":1431613953000},"page":"1429-1440","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":156,"title":["Neuropathobiology of non-motor symptoms in Parkinson disease"],"prefix":"10.1007","volume":"122","author":[{"given":"Kurt A.","family":"Jellinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"1405_CR1","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","volume":"24","author":"D Aarsland","year":"2009","unstructured":"Aarsland D, Marsh L, Schrag A (2009) Neuropsychiatric symptoms in Parkinson\u2019s disease. Mov Disord 24:2175\u20132186","journal-title":"Mov Disord"},{"key":"1405_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000122963","volume":"25","author":"L Aho","year":"2008","unstructured":"Aho L, Parkkinen L, Pirttila T, Alafuzoff I (2008) Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects. Dement Geriatr Cogn Disord 25:423\u2013432","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1405_CR3","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1586\/ern.12.144","volume":"12","author":"RS Akhtar","year":"2012","unstructured":"Akhtar RS, Stern MB (2012) New concepts in the early and preclinical detection of Parkinson\u2019s disease: therapeutic implications. Expert Rev Neurother 12:1429\u20131438","journal-title":"Expert Rev Neurother"},{"key":"1405_CR4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.brainres.2003.10.073","volume":"1000","author":"TF Almeida","year":"2004","unstructured":"Almeida TF, Roizenblatt S, Tufik S (2004) Afferent pain pathways: a neuroanatomical review. Brain Res 1000:40\u201356","journal-title":"Brain Res"},{"key":"1405_CR5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1750-3639.2005.tb00097.x","volume":"15","author":"T Amino","year":"2005","unstructured":"Amino T, Orimo S, Itoh Y, Takahashi A, Uchihara T, Mizusawa H (2005) Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol 15:29\u201334","journal-title":"Brain Pathol"},{"key":"1405_CR6","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.expneurol.2007.05.010","volume":"207","author":"G Anderson","year":"2007","unstructured":"Anderson G, Noorian AR, Taylor G, Anitha M, Bernhard D, Srinivasan S, Greene JG (2007) Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson\u2019s disease. Exp Neurol 207:4\u201312","journal-title":"Exp Neurol"},{"key":"1405_CR7","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","volume":"132","author":"NK Archibald","year":"2009","unstructured":"Archibald NK, Clarke MP, Mosimann UP, Burn DJ (2009) The retina in Parkinson\u2019s disease. Brain 132:1128\u20131145","journal-title":"Brain"},{"key":"1405_CR8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00401-014-1261-7","volume":"127","author":"J Attems","year":"2014","unstructured":"Attems J, Walker L, Jellinger KA (2014) Olfactory bulb involvement in neurodegenerative diseases. Acta Neuropathol 127:459\u2013475","journal-title":"Acta Neuropathol"},{"key":"1405_CR9","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L, Sue LI, Bachalakuri J, Henry-Watson J, Sasse J, Boyer S, Shirohi S, Brooks R, Eschbacher J, White CL 3rd, Akiyama H, Caviness J, Shill HA, Connor DJ, Sabbagh MN, Walker DG (2009a) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117:613\u2013634","journal-title":"Acta Neuropathol"},{"key":"1405_CR10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00401-008-0450-7","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, White CL 3rd, Hladik CL, Sabbagh MN, Connor DJ, Shill HA, Sue LI, Sasse J, Bachalakuri J, Henry-Watson J, Akiyama H, Adler CH (2009b) Olfactory bulb alpha-synucleinopathy has high specificity and sensitivity for Lewy body disorders. Acta Neuropathol 117:169\u2013174","journal-title":"Acta Neuropathol"},{"key":"1405_CR11","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00401-010-0664-3","volume":"119","author":"TG Beach","year":"2010","unstructured":"Beach TG, Adler CH, Sue LI, Vedders L, Lue L, White Iii CL, Akiyama H, Caviness JN, Shill HA, Sabbagh MN, Walker DG (2010) Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol 119:689\u2013702","journal-title":"Acta Neuropathol"},{"key":"1405_CR12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","volume":"571","author":"TG Beach","year":"2014","unstructured":"Beach TG, Carew J, Serrano G, Adler CH, Shill HA, Sue LI, Sabbagh MN, Akiyama H, Cuenca N (2014) Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects. Neurosci Lett 571:34\u201338","journal-title":"Neurosci Lett"},{"key":"1405_CR13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","volume":"20","author":"H Bernheimer","year":"1973","unstructured":"Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F (1973) Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. J Neurol Sci 20:415\u2013455","journal-title":"J Neurol Sci"},{"key":"1405_CR14","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neulet.2009.10.035","volume":"467","author":"F Blandini","year":"2009","unstructured":"Blandini F, Balestra B, Levandis G, Cervio M, Greco R, Tassorelli C, Colucci M, Faniglione M, Bazzini E, Nappi G, Clavenzani P, Vigneri S, De Giorgio R, Tonini M (2009) Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson\u2019s disease. Neurosci Lett 467:203\u2013207","journal-title":"Neurosci Lett"},{"key":"1405_CR15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2006.00727.x","volume":"32","author":"A Bloch","year":"2006","unstructured":"Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 32:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1405_CR16","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1155\/2011\/143857","volume":"24","author":"LX Blonder","year":"2011","unstructured":"Blonder LX, Slevin JT (2011) Emotional dysfunction in Parkinson\u2019s disease. Behav Neurol 24:201\u2013217","journal-title":"Behav Neurol"},{"key":"1405_CR17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/ana.24182","volume":"75","author":"I Bodis-Wollner","year":"2014","unstructured":"Bodis-Wollner I, Kozlowski PB, Glazman S, Miri S (2014) Alpha-synuclein in the inner retina in parkinson disease. Ann Neurol 75:964\u2013966","journal-title":"Ann Neurol"},{"key":"1405_CR18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2009.05115.x","volume":"1184","author":"BF Boeve","year":"2010","unstructured":"Boeve BF (2010) REM sleep behavior disorder: updated review of the core features, the REM sleep behavior disorder-neurodegenerative disease association, evolving concepts, controversies, and future directions. Ann N Y Acad Sci 1184:15\u201354","journal-title":"Ann N Y Acad Sci"},{"key":"1405_CR19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/WNL.51.2.363","volume":"51","author":"BF Boeve","year":"1998","unstructured":"Boeve BF, Silber MH, Ferman TJ, Kokmen E, Smith GE, Ivnik RJ, Parisi JE, Olson EJ, Petersen RC (1998) REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 51:363\u2013370","journal-title":"Neurology"},{"key":"1405_CR20","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1093\/brain\/awm056","volume":"130","author":"BF Boeve","year":"2007","unstructured":"Boeve BF, Silber MH, Saper CB, Ferman TJ, Dickson DW, Parisi JE, Benarroch EE, Ahlskog JE, Smith GE, Caselli RC, Tippman-Peikert M, Olson EJ, Lin SC, Young T, Wszolek Z, Schenck CH, Mahowald MW, Castillo PR, Del Tredici K, Braak H (2007) Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 130:2770\u20132788","journal-title":"Brain"},{"key":"1405_CR21","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000312279.49272.9f","volume":"70","author":"H Braak","year":"2008","unstructured":"Braak H, Del Tredici K (2008) Nervous system pathology in sporadic Parkinson disease. Neurology 70:1916\u20131925","journal-title":"Neurology"},{"key":"1405_CR22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging 24:197\u2013211","journal-title":"Neurobiol Aging"},{"key":"1405_CR23","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1212\/01.WNL.0000158422.41380.82","volume":"64","author":"H Braak","year":"2005","unstructured":"Braak H, Rub U, Jansen Steur EN, Del Tredici K, de Vos RA (2005) Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology 64:1404\u20131410","journal-title":"Neurology"},{"key":"1405_CR24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","volume":"396","author":"H Braak","year":"2006","unstructured":"Braak H, de Vos RA, Bohl J, Del Tredici K (2006) Gastric alpha-synuclein immunoreactive inclusions in Meissner\u2019s and Auerbach\u2019s plexuses in cases staged for Parkinson\u2019s disease-related brain pathology. Neurosci Lett 396:67\u201372","journal-title":"Neurosci Lett"},{"key":"1405_CR25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00401-007-0193-x","volume":"113","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Bohl JR, de Vos RA, Del Tredici K (2007) Parkinson\u2019s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons. Acta Neuropathol 113:421\u2013429","journal-title":"Acta Neuropathol"},{"key":"1405_CR26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00702-012-0928-2","volume":"120","author":"KC Breen","year":"2013","unstructured":"Breen KC, Drutyte G (2013) Non-motor symptoms of Parkinson\u2019s disease: the patient\u2019s perspective. J Neural Transm 120:531\u2013535","journal-title":"J Neural Transm"},{"key":"1405_CR27","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.21541","volume":"64","author":"RE Burke","year":"2008","unstructured":"Burke RE, Dauer WT, Vonsattel JP (2008) A critical evaluation of the Braak staging scheme for Parkinson\u2019s disease. Ann Neurol 64:485\u2013491","journal-title":"Ann Neurol"},{"key":"1405_CR28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/B978-1-4160-6641-5.00012-X","volume-title":"Movement Disorders 4","author":"DJ Burn","year":"2010","unstructured":"Burn DJ (2010) Dementia in Parkinson\u2019s disease. In: Schapira AHV, Lang AET, Fahn S (eds) Movement Disorders 4. Saunders-Elsevier, Philadelphia, pp 188\u2013212"},{"key":"1405_CR29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/mds.22051","volume":"23","author":"MG Cersosimo","year":"2008","unstructured":"Cersosimo MG, Benarroch EE (2008) Neural control of the gastrointestinal tract: implications for Parkinson disease. Mov Disord 23:1065\u20131075","journal-title":"Mov Disord"},{"key":"1405_CR30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8:464\u2013474","journal-title":"Lancet Neurol"},{"key":"1405_CR31","doi-asserted-by":"crossref","unstructured":"Chaudhuri KR, Tolosa E, Schapira A, Poewe W (eds) (2009) Non-motor symptoms of parkinson\u2019s disease. Oxford Univ. Press, Oxford","DOI":"10.1093\/med\/9780199237234.001.0001"},{"key":"1405_CR32","doi-asserted-by":"crossref","unstructured":"Chaudhuri KR, Tolosa E, Schapira A, Poewe W (eds) (2014) Non-motor symptoms of Parkinson\u2019s disease, 2nd edn. Oxford Univ. Press, Oxford","DOI":"10.1093\/med\/9780199684243.001.0001"},{"key":"1405_CR33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2982.2008.01226.x","volume":"21","author":"T Chaumette","year":"2009","unstructured":"Chaumette T, Lebouvier T, Aubert P, Lardeux B, Qin C, Li Q, Accary D, Bezard E, Bruley des Varannes S, Derkinderen P, Neunlist M (2009) Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism. Neurogastroenterol Motil 21:215\u2013222","journal-title":"Neurogastroenterol Motil"},{"key":"1405_CR34","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67:715\u2013725","journal-title":"Ann Neurol"},{"key":"1405_CR35","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1212\/WNL.0b013e3181ec7fac","volume":"75","author":"DO Claassen","year":"2010","unstructured":"Claassen DO, Josephs KA, Ahlskog JE, Silber MH, Tippmann-Peikert M, Boeve BF (2010) REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century. Neurology 75:494\u2013499","journal-title":"Neurology"},{"key":"1405_CR36","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/jnnp.74.7.852","volume":"74","author":"C Colosimo","year":"2003","unstructured":"Colosimo C, Hughes AJ, Kilford L, Lees AJ (2003) Lewy body cortical involvement may not always predict dementia in Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 74:852\u2013856","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1405_CR37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00415-009-5255-7","volume":"257","author":"C Colosimo","year":"2010","unstructured":"Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, Marconi R (2010) Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257:5\u201314","journal-title":"J Neurol"},{"key":"1405_CR38","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00702-005-0431-0","volume":"113","author":"R Dabby","year":"2006","unstructured":"Dabby R, Djaldetti R, Shahmurov M, Treves TA, Gabai B, Melamed E, Sadeh M, Avinoach I (2006) Skin biopsy for assessment of autonomic denervation in Parkinson\u2019s disease. J Neural Transm 113:1169\u20131176","journal-title":"J Neural Transm"},{"key":"1405_CR39","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archneurol.2008.2","volume":"65","author":"G Defazio","year":"2008","unstructured":"Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M (2008) Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study. Arch Neurol 65:1191\u20131194","journal-title":"Arch Neurol"},{"key":"1405_CR40","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Tredici Del","year":"2010","unstructured":"Del Tredici K, Hawkes CH, Ghebremedhin E, Braak H (2010) Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol 119:703\u2013713","journal-title":"Acta Neuropathol"},{"key":"1405_CR41","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1001\/archneur.65.8.1074","volume":"65","author":"A DelleDonne","year":"2008","unstructured":"DelleDonne A, Klos KJ, Fujishiro H, Ahmed Z, Parisi JE, Josephs KA, Frigerio R, Burnett M, Wszolek ZK, Uitti RJ, Ahlskog JE, Dickson DW (2008) Incidental Lewy body disease and preclinical Parkinson disease. Arch Neurol 65:1074\u20131080","journal-title":"Arch Neurol"},{"issue":"Suppl 3","key":"1405_CR42","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson DW, Fujishiro H, Orr C, DelleDonne A, Josephs KA, Frigerio R, Burnett M, Parisi JE, Klos KJ, Ahlskog JE (2009) Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat Disord 15(Suppl 3):S1\u2013S5","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 1","key":"1405_CR43","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1002\/mds.22637","volume":"25","author":"DW Dickson","year":"2010","unstructured":"Dickson DW, Uchikado H, Fujishiro H, Tsuboi Y (2010) Evidence in favor of Braak staging of Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S78\u2013S82","journal-title":"Mov Disord"},{"key":"1405_CR44","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/mds.22172","volume":"24","author":"R Djaldetti","year":"2009","unstructured":"Djaldetti R, Lev N, Melamed E (2009) Lesions outside the CNS in Parkinson\u2019s disease. Mov Disord 24:793\u2013800","journal-title":"Mov Disord"},{"key":"1405_CR45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","volume":"128","author":"K Doppler","year":"2014","unstructured":"Doppler K, Ebert S, Uceyler N, Trenkwalder C, Ebentheuer J, Volkmann J, Sommer C (2014) Cutaneous neuropathy in Parkinson\u2019s disease: a window into brain pathology. Acta Neuropathol 128:99\u2013109","journal-title":"Acta Neuropathol"},{"key":"1405_CR46","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.nbd.2009.06.017","volume":"36","author":"RE Drolet","year":"2009","unstructured":"Drolet RE, Cannon JR, Montero L, Greenamyre JT (2009) Chronic rotenone exposure reproduces Parkinson\u2019s disease gastrointestinal neuropathology. Neurobiol Dis 36:96\u2013102","journal-title":"Neurobiol Dis"},{"key":"1405_CR47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jns.2009.08.042","volume":"289","author":"JE Duda","year":"2010","unstructured":"Duda JE (2010) Olfactory system pathology as a model of Lewy neurodegenerative disease. J Neurol Sci 289:49\u201354","journal-title":"J Neurol Sci"},{"key":"1405_CR48","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22:1689\u20131707 quiz 1837","journal-title":"Mov Disord"},{"key":"1405_CR49","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mds.21765","volume":"23","author":"A Feldmann","year":"2008","unstructured":"Feldmann A, Illes Z, Kosztolanyi P, Illes E, Mike A, Kover F, Balas I, Kovacs N, Nagy F (2008) Morphometric changes of gray matter in Parkinson\u2019s disease with depression: a voxel-based morphometry study. Mov Disord 23:42\u201346","journal-title":"Mov Disord"},{"key":"1405_CR50","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00702-010-0482-8","volume":"118","author":"I Ferrer","year":"2010","unstructured":"Ferrer I, Martinez A, Blanco R, Dalfo E, Carmona M (2010) Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. J Neural Transm 118:821\u2013839","journal-title":"J Neural Transm"},{"key":"1405_CR51","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1460-9568.2008.06346.x","volume":"28","author":"SM Fleming","year":"2008","unstructured":"Fleming SM, Tetreault NA, Mulligan CK, Hutson CB, Masliah E, Chesselet MF (2008) Olfactory deficits in mice overexpressing human wildtype alpha-synuclein. Eur J Neurosci 28:247\u2013256","journal-title":"Eur J Neurosci"},{"key":"1405_CR52","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1532-5415.1969.tb01316.x","volume":"17","author":"LS Forno","year":"1969","unstructured":"Forno LS (1969) Concentric hyalin intraneuronal inclusions of Lewy type in the brains of elderly persons (50 incidental cases): relationship to parkinsonism. J Am Geriatr Soc 17:557\u2013575","journal-title":"J Am Geriatr Soc"},{"key":"1405_CR53","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/nen.0b013e3180517454","volume":"66","author":"Y Fumimura","year":"2007","unstructured":"Fumimura Y, Ikemura M, Saito Y, Sengoku R, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Mizusawa H, Murayama S (2007) Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66:354\u2013362","journal-title":"J Neuropathol Exp Neurol"},{"key":"1405_CR54","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/ene.12382","volume":"21","author":"A Gaenslen","year":"2014","unstructured":"Gaenslen A, Wurster I, Brockmann K, Huber H, Godau J, Faust B, Lerche S, Eschweiler GW, Maetzler W, Berg D (2014) Prodromal features for Parkinson\u2019s disease\u2013baseline data from the TREND study. Eur J Neurol 21:766\u2013772","journal-title":"Eur J Neurol"},{"issue":"Suppl 2","key":"1405_CR55","doi-asserted-by":"crossref","first-page":"S656","DOI":"10.1002\/mds.22672","volume":"24","author":"C Gaig","year":"2009","unstructured":"Gaig C, Tolosa E (2009) When does Parkinson\u2019s disease begin? Mov Disord 24(Suppl 2):S656\u2013S664","journal-title":"Mov Disord"},{"key":"1405_CR56","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nbd.2011.12.041","volume":"46","author":"DA Gallagher","year":"2012","unstructured":"Gallagher DA, Schrag A (2012) Psychosis, apathy, depression and anxiety in Parkinson\u2019s disease. Neurobiol Dis 46:581\u2013589","journal-title":"Neurobiol Dis"},{"key":"1405_CR57","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/mds.23394","volume":"25","author":"DA Gallagher","year":"2010","unstructured":"Gallagher DA, Lees AJ, Schrag A (2010) What are the most important nonmotor symptoms in patients with Parkinson\u2019s disease and are we missing them? Mov Disord 25:2493\u20132500","journal-title":"Mov Disord"},{"key":"1405_CR58","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00702-011-0682-x","volume":"119","author":"M Gerlach","year":"2012","unstructured":"Gerlach M, Maetzler W, Broich K, Hampel H, Rems L, Reum T, Riederer P, Stoffler A, Streffer J, Berg D (2012) Biomarker candidates of neurodegeneration in Parkinson\u2019s disease for the evaluation of disease-modifying therapeutics. J Neural Transm 119:39\u201352","journal-title":"J Neural Transm"},{"key":"1405_CR59","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s00401-009-0596-y","volume":"118","author":"E Ghebremedhin","year":"2009","unstructured":"Ghebremedhin E, Del Tredici K, Langston JW, Braak H (2009) Diminished tyrosine hydroxylase immunoreactivity in the cardiac conduction system and myocardium in Parkinson\u2019s disease: an anatomical study. Acta Neuropathol 118:777\u2013784","journal-title":"Acta Neuropathol"},{"issue":"Suppl 2","key":"1405_CR60","first-page":"S81","volume":"64","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Emre M, Dubois B (2008) Parkinson\u2019s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol 64(Suppl 2):S81\u2013S92","journal-title":"Ann Neurol"},{"key":"1405_CR61","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.expneurol.2009.04.023","volume":"218","author":"JG Greene","year":"2009","unstructured":"Greene JG, Noorian AR, Srinivasan S (2009) Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson\u2019s disease. Exp Neurol 218:154\u2013161","journal-title":"Exp Neurol"},{"key":"1405_CR62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2009.08.021","volume":"289","author":"LT Grinberg","year":"2010","unstructured":"Grinberg LT, Rueb U, Alho AT, Heinsen H (2010) Brainstem pathology and non-motor symptoms in PD. J Neurol Sci 289:81\u201388","journal-title":"J Neurol Sci"},{"key":"1405_CR63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2047-9158-1-11","volume":"1","author":"BR Haas","year":"2012","unstructured":"Haas BR, Stewart TH, Zhang J (2012) Premotor biomarkers for Parkinson\u2019s disease\u2014a promising direction of research. Transl Neurodegener 1:11","journal-title":"Transl Neurodegener"},{"key":"1405_CR64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/B978-1-4160-6641-5.00009-X","volume-title":"Movement disorders 4","author":"G Halliday","year":"2010","unstructured":"Halliday G, Murphy K (2010) Pathology of Parkinson\u2019s disease. In: Schapira AHV, Lang AET, Fahn S (eds) Movement disorders 4. Saunders-Elsevier, Philadelphia, pp 132\u2013154"},{"key":"1405_CR65","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","volume":"16","author":"CH Hawkes","year":"2010","unstructured":"Hawkes CH, Del Tredici K, Braak H (2010) A timeline for Parkinson\u2019s disease. Parkinsonism Relat Disord 16:79\u201384","journal-title":"Parkinsonism Relat Disord"},{"key":"1405_CR66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23:837\u2013844","journal-title":"Mov Disord"},{"key":"1405_CR67","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bjorklund T, Wang ZY, Roybon L, Melki R, Li JY (2014) Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol 128:805\u2013820","journal-title":"Acta Neuropathol"},{"key":"1405_CR68","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/WNL.54.10.1916","volume":"54","author":"HI Hurtig","year":"2000","unstructured":"Hurtig HI, Trojanowski JQ, Galvin J, Ewbank D, Schmidt ML, Lee VM, Clark CM, Glosser G, Stern MB, Gollomp SM, Arnold SE (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson\u2019s disease. Neurology 54:1916\u20131921","journal-title":"Neurology"},{"key":"1405_CR69","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/mds.23001","volume":"25","author":"M Iijima","year":"2010","unstructured":"Iijima M, Osawa M, Momose M, Kobayakawa T, Saito S, Iwata M, Uchiyama S (2010) Cardiac sympathetic degeneration correlates with olfactory function in Parkinson\u2019s disease. Mov Disord 25:1143\u20131149","journal-title":"Mov Disord"},{"key":"1405_CR70","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/NEN.0b013e318186de48","volume":"67","author":"M Ikemura","year":"2008","unstructured":"Ikemura M, Saito Y, Sengoku R, Sakiyama Y, Hatsuta H, Kanemaru K, Sawabe M, Arai T, Ito G, Iwatsubo T, Fukayama M, Murayama S (2008) Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67:945\u2013953","journal-title":"J Neuropathol Exp Neurol"},{"key":"1405_CR71","first-page":"162","volume":"6","author":"PG Ince","year":"1995","unstructured":"Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer\u2019s disease, Lewy body disease, vascular lesions. Dementia 6:162\u2013168","journal-title":"Dementia"},{"key":"1405_CR72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/med\/9780199237234.003.0014","volume-title":"Non-motor symptoms of Parkinson\u2019s disease","author":"A Iranzo","year":"2009","unstructured":"Iranzo A, Tolosa E (2009) REM sleep behaviour disorder in Parkinson\u2019s disease. In: Chaudhuri KR, Tolosa E, Schapira A, Poewe W (eds) Non-motor symptoms of Parkinson\u2019s disease. Oxford Univ. Press, Oxford, pp 177\u2013193"},{"key":"1405_CR73","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1474-4422(06)70476-8","volume":"5","author":"A Iranzo","year":"2006","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, Serradell M, Marti MJ, Valldeoriola F, Tolosa E (2006) Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 5:572\u2013577","journal-title":"Lancet Neurol"},{"key":"1405_CR74","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1212\/WNL.52.6.1269","volume":"52","author":"K Iwanaga","year":"1999","unstructured":"Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson\u2019s and incidental Lewy body diseases. Neurology 52:1269\u20131271","journal-title":"Neurology"},{"key":"1405_CR75","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00702-004-0138-7","volume":"111","author":"KA Jellinger","year":"2004","unstructured":"Jellinger KA (2004) Lewy body-related alpha-synucleinopathy in the aged human brain. J Neural Transm 111:1219\u20131235","journal-title":"J Neural Transm"},{"key":"1405_CR76","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2006.05.002","volume":"248","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA (2006) The morphological basis of mental dysfunction in Parkinson\u2019s disease. J Neurol Sci 248:167\u2013172","journal-title":"J Neurol Sci"},{"key":"1405_CR77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0406-y","volume":"116","author":"KA Jellinger","year":"2008","unstructured":"Jellinger KA (2008) A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathol 116:1\u201316","journal-title":"Acta Neuropathol"},{"key":"1405_CR78","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.bbadis.2008.07.006","volume":"1792","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009a) A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders. Biochim Biophys Acta 1792:730\u2013740","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 3","key":"1405_CR79","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00415-009-5243-y","volume":"256","author":"KA Jellinger","year":"2009","unstructured":"Jellinger KA (2009b) Formation and development of Lewy pathology: a critical update. J Neurol 256(Suppl 3):270\u2013279","journal-title":"J Neurol"},{"key":"1405_CR80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00401-009-0613-1","volume":"119","author":"KA Jellinger","year":"2010","unstructured":"Jellinger KA (2010) The neuropathologic substrate of Parkinson disease dementia. Acta Neuropathol 119:151\u2013153","journal-title":"Acta Neuropathol"},{"key":"1405_CR81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jns.2011.04.012","volume":"310","author":"KA Jellinger","year":"2011","unstructured":"Jellinger KA (2011) Synuclein deposition and non-motor symptoms in Parkinson disease. J Neurol Sci 310:107\u2013111","journal-title":"J Neurol Sci"},{"key":"1405_CR82","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1586\/ern.12.131","volume":"12","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012a) Neurobiology of cognitive impairment in Parkinson\u2019s disease. Expert Rev Neurother 12:1451\u20131466","journal-title":"Expert Rev Neurother"},{"key":"1405_CR83","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/mds.23795","volume":"27","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012b) Neuropathology of sporadic Parkinson\u2019s disease: evaluation and changes of concepts. Mov Disord 27:8\u201330","journal-title":"Mov Disord"},{"key":"1405_CR84","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2478\/s13380-012-0013-1","volume":"3","author":"KA Jellinger","year":"2012","unstructured":"Jellinger KA (2012c) The role of alpha-synuclein in neurodegeneration\u2014an update. Translat Neurosci 3:75\u2013122","journal-title":"Translat Neurosci"},{"key":"1405_CR85","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00702-012-0771-5","volume":"120","author":"KA Jellinger","year":"2013","unstructured":"Jellinger KA (2013) Mild cognitive impairment in Parkinson disease: heterogenous mechanisms. J Neural Transm 120:157\u2013167","journal-title":"J Neural Transm"},{"key":"1405_CR86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/978-3-319-08046-8_2","volume-title":"Inflammation in Parkinson\u2019s disease: scientific and clinical aspects","author":"KA Jellinger","year":"2014","unstructured":"Jellinger KA (2014) Neuropathology of Parkinson\u2019s disease. In: Thomas M (ed) Inflammation in Parkinson\u2019s disease: scientific and clinical aspects. Springer, New York, pp 25\u201374"},{"key":"1405_CR87","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jns.2009.08.018","volume":"289","author":"C Juri","year":"2010","unstructured":"Juri C, Rodriguez-Oroz M, Obeso JA (2010) The pathophysiological basis of sensory disturbances in Parkinson\u2019s disease. J Neurol Sci 289:60\u201365","journal-title":"J Neurol Sci"},{"key":"1405_CR88","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00401-009-0597-x","volume":"118","author":"ME Kalaitzakis","year":"2009","unstructured":"Kalaitzakis ME, Pearce RK (2009) The morbid anatomy of dementia in Parkinson\u2019s disease. Acta Neuropathol 118:587\u2013598","journal-title":"Acta Neuropathol"},{"key":"1405_CR89","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00401-008-0381-3","volume":"116","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008a) Controversies over the staging of alpha-synuclein pathology in Parkinson\u2019s disease. Acta Neuropathol 116:125\u2013128 author reply 129\u2013131","journal-title":"Acta Neuropathol"},{"key":"1405_CR90","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1365-2990.2007.00923.x","volume":"34","author":"ME Kalaitzakis","year":"2008","unstructured":"Kalaitzakis ME, Graeber MB, Gentleman SM, Pearce RK (2008b) The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson\u2019s disease: a critical analysis of alpha-synuclein staging. Neuropathol Appl Neurobiol 34:284\u2013295","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1405_CR91","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/nmo.12459","volume":"26","author":"H Karasawa","year":"2014","unstructured":"Karasawa H, Pietra C, Giuliano C, Garcia-Rubio S, Xu X, Yakabi S, Tache Y, Wang L (2014) New ghrelin agonist, HM01 alleviates constipation and l-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson\u2019s disease. Neurogastroenterol Motil 26:1771\u20131782","journal-title":"Neurogastroenterol Motil"},{"key":"1405_CR92","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/archneurol.67.6.670","volume":"67","author":"M Kasten","year":"2010","unstructured":"Kasten M, Kertelge L, Bruggemann N, van der Vegt J, Schmidt A, Tadic V, Buhmann C, Steinlechner S, Behrens MI, Ramirez A, Binkofski F, Siebner H, Raspe H, Hagenah J, Lencer R, Klein C (2010) Nonmotor symptoms in genetic Parkinson disease. Arch Neurol 67:670\u2013676","journal-title":"Arch Neurol"},{"key":"1405_CR93","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol 9:1200\u20131213","journal-title":"Lancet Neurol"},{"key":"1405_CR94","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-1331.2009.02854.x","volume":"17","author":"YK Kim","year":"2010","unstructured":"Kim YK, Yoon IY, Kim JM, Jeong SH, Kim KW, Shin YK, Kim BS, Kim SE (2010) The implication of nigrostriatal dopaminergic degeneration in the pathogenesis of REM sleep behavior disorder. Eur J Neurol 17:487\u2013492","journal-title":"Eur J Neurol"},{"key":"1405_CR95","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, Maeir H, Poewe W, Lees AJ (2010) Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord 25:2508\u20132515","journal-title":"Mov Disord"},{"key":"1405_CR96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2009.08.032","volume":"289","author":"AD Korczyn","year":"2010","unstructured":"Korczyn AD, Gurevich T (2010) Parkinson\u2019s disease: before the motor symptoms and beyond. J Neurol Sci 289:2\u20136","journal-title":"J Neurol Sci"},{"key":"1405_CR97","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/mds.22207","volume":"23","author":"GG Kovacs","year":"2008","unstructured":"Kovacs GG, Milenkovic IJ, Preusser M, Budka H (2008) Nigral burden of alpha-synuclein correlates with striatal dopamine deficit. Mov Disord 23:1608\u20131612","journal-title":"Mov Disord"},{"key":"1405_CR98","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/hmg\/ddq038","volume":"19","author":"YM Kuo","year":"2010","unstructured":"Kuo YM, Li Z, Jiao Y, Gaborit N, Pani AK, Orrison BM, Bruneau BG, Giasson BI, Smeyne RJ, Gershon MD, Nussbaum RL (2010) Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet 19:1633\u20131650","journal-title":"Hum Mol Genet"},{"key":"1405_CR99","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mds.23609","volume":"26","author":"AE Lang","year":"2011","unstructured":"Lang AE (2011) A critical appraisal of the premotor symptoms of Parkinson\u2019s disease: potential usefulness in early diagnosis and design of neuroprotective trials. Mov Disord 26:775\u2013783","journal-title":"Mov Disord"},{"key":"1405_CR100","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","volume":"339","author":"AE Lang","year":"1998","unstructured":"Lang AE, Lozano AM (1998) Parkinson\u2019s disease. First of two parts. N Engl J Med 339:1044\u20131053","journal-title":"N Engl J Med"},{"key":"1405_CR101","doi-asserted-by":"crossref","first-page":"e12728","DOI":"10.1371\/journal.pone.0012728","volume":"5","author":"T Lebouvier","year":"2010","unstructured":"Lebouvier T, Neunlist M, Bruley des Varannes S, Coron E, Drouard A, N\u2019Guyen JM, Chaumette T, Tasselli M, Paillusson S, Flamand M, Galmiche JP, Damier P, Derkinderen P (2010) Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One 5:e12728","journal-title":"PLoS One"},{"key":"1405_CR102","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00415-013-7171-0","volume":"261","author":"S Lerche","year":"2014","unstructured":"Lerche S, Seppi K, Behnke S, Liepelt-Scarfone I, Godau J, Mahlknecht P, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Poewe W, Berg D (2014) Risk factors and prodromal markers and the development of Parkinson\u2019s disease. J Neurol 261:180\u2013187","journal-title":"J Neurol"},{"key":"1405_CR103","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.parkreldis.2014.11.018","volume":"21","author":"S Lerche","year":"2015","unstructured":"Lerche S, Brockmann K, Wurster I, Gaenslen A, Roeben B, Holz D, Eschweiler GW, Maetzler W, Berg D (2015) Reasons for mild parkinsonian signs\u2014which constellation may indicate neurodegeneration? Parkinsonism Relat Disord 21:126\u2013130","journal-title":"Parkinsonism Relat Disord"},{"key":"1405_CR104","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00702-010-0553-x","volume":"118","author":"I Liepelt-Scarfone","year":"2011","unstructured":"Liepelt-Scarfone I, Behnke S, Godau J, Schweitzer KJ, Wolf B, Gaenslen A, Berg D (2011) Relation of risk factors and putative premotor markers for Parkinson\u2019s disease. J Neural Transm 118:579\u2013585","journal-title":"J Neural Transm"},{"key":"1405_CR105","first-page":"167","volume":"66","author":"SY Lim","year":"2009","unstructured":"Lim SY, Fox SH, Lang AE (2009) Overview of the extranigral aspects of Parkinson disease. Arch Neurol 66:167\u2013172","journal-title":"Arch Neurol"},{"key":"1405_CR106","first-page":"1353","volume":"66","author":"RY Lo","year":"2009","unstructured":"Lo RY, Tanner CM, Albers KB, Leimpeter AD, Fross RD, Bernstein AL, McGuire V, Quesenberry CP, Nelson LM, Van Den Eeden SK (2009) Clinical features in early Parkinson disease and survival. Arch Neurol 66:1353\u20131358","journal-title":"Arch Neurol"},{"key":"1405_CR107","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2217\/nmt.12.74","volume":"3","author":"P Mahlknecht","year":"2013","unstructured":"Mahlknecht P, Poewe W (2013) Defining premotor Parkinson\u2019s disease: a window of opportunity for neuroprotection? Neurodegen Dis Manage 3:61\u201370","journal-title":"Neurodegen Dis Manage"},{"key":"1405_CR108","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000348595","volume":"12","author":"P Mahlknecht","year":"2013","unstructured":"Mahlknecht P, Seppi K, Stockner H, Nocker M, Scherfler C, Kiechl S, Willeit J, Schmidauer C, Gasperi A, Rungger G, Poewe W (2013) Substantia nigra hyperechogenicity as a marker for Parkinson\u2019s disease: a population-based study. Neurodegener Dis 12:212\u2013218","journal-title":"Neurodegener Dis"},{"issue":"Suppl 1","key":"1405_CR109","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/mds.22787","volume":"25","author":"K Marder","year":"2010","unstructured":"Marder K (2010) Cognitive impairment and dementia in Parkinson\u2019s disease. Mov Disord 25(Suppl 1):S110\u2013S116","journal-title":"Mov Disord"},{"key":"1405_CR110","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/mds.21586","volume":"22","author":"P Martinez-Martin","year":"2007","unstructured":"Martinez-Martin P, Schapira AH, Stocchi F, Sethi K, Odin P, MacPhee G, Brown RG, Naidu Y, Clayton L, Abe K, Tsuboi Y, MacMahon D, Barone P, Rabey M, Bonuccelli U, Forbes A, Breen K, Tluk S, Olanow CW, Thomas S, Rye D, Hand A, Williams AJ, Ondo W, Chaudhuri KR (2007) Prevalence of nonmotor symptoms in Parkinson\u2019s disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients. Mov Disord 22:1623\u20131629","journal-title":"Mov Disord"},{"key":"1405_CR111","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/ene.12165","volume":"22","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin P, Chaudhuri KR, Rojo-Abuin JM, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, Garretto N, Gershanik O, Kurtis MM, Martinez-Castrillo JC, Mendoza-Rodriguez A, Moore HP, Rodriguez-Violante M, Singer C, Tilley BC, Huang J, Stebbins GT, Goetz CG (2015) Assessing the non-motor symptoms of Parkinson\u2019s disease: MDS-UPDRS and NMS Scale. Eur J Neurol 22:37\u201343","journal-title":"Eur J Neurol"},{"key":"1405_CR112","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s004019900168","volume":"100","author":"PM Mattila","year":"2000","unstructured":"Mattila PM, Rinne JO, Helenius H, Dickson DW, Roytta M (2000) Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson\u2019s disease. Acta Neuropathol 100:285\u2013290","journal-title":"Acta Neuropathol"},{"key":"1405_CR113","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0301-0082(02)00009-6","volume":"66","author":"MJ Millan","year":"2002","unstructured":"Millan MJ (2002) Descending control of pain. Prog Neurobiol 66:355\u2013474","journal-title":"Prog Neurobiol"},{"key":"1405_CR114","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1212\/01.wnl.0000264429.59379.d9","volume":"68","author":"A Minguez-Castellanos","year":"2007","unstructured":"Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, Rebollo AC, Gomez-Rio M, Concha A, Munoz DG (2007) Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study. Neurology 68:2012\u20132018","journal-title":"Neurology"},{"key":"1405_CR115","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.parkreldis.2014.03.024","volume":"20","author":"JF Morley","year":"2014","unstructured":"Morley JF, Pawlowski SM, Kesari A, Maina I, Pantelyat A, Duda JE (2014) Motor and non-motor features of Parkinson\u2019s disease that predict persistent drug-induced Parkinsonism. Parkinsonism Relat Disord 20:738\u2013742","journal-title":"Parkinsonism Relat Disord"},{"key":"1405_CR116","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/01.jnen.0000171652.40083.15","volume":"64","author":"CM Muller","year":"2005","unstructured":"Muller CM, de Vos RA, Maurage CA, Thal DR, Tolnay M, Braak H (2005) Staging of sporadic Parkinson disease-related alpha-synuclein pathology: inter- and intra-rater reliability. J Neuropathol Exp Neurol 64:623\u2013628","journal-title":"J Neuropathol Exp Neurol"},{"key":"1405_CR117","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/brain\/awn102","volume":"131","author":"M Nolano","year":"2008","unstructured":"Nolano M, Provitera V, Estraneo A, Selim MM, Caporaso G, Stancanelli A, Saltalamacchia AM, Lanzillo B, Santoro L (2008) Sensory deficit in Parkinson\u2019s disease: evidence of a cutaneous denervation. Brain 131:1903\u20131911","journal-title":"Brain"},{"key":"1405_CR118","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","volume":"72","author":"AJ Noyce","year":"2012","unstructured":"Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Giovannoni G, Lees AJ, Schrag A (2012) Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol 72:893\u2013901","journal-title":"Ann Neurol"},{"key":"1405_CR119","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00401-009-0629-6","volume":"119","author":"M Oinas","year":"2010","unstructured":"Oinas M, Paetau A, Myllykangas L, Notkola IL, Kalimo H, Polvikoski T (2010) alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85\u00a0+\u00a0study. Acta Neuropathol 119:715\u2013722","journal-title":"Acta Neuropathol"},{"key":"1405_CR120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1440-1827.2004.01680.x","volume":"54","author":"Y Okada","year":"2004","unstructured":"Okada Y, Ito Y, Aida J, Yasuhara M, Ohkawa S, Hirokawa K (2004) Lewy bodies in the sinoatrial nodal ganglion: clinicopathological studies. Pathol Int 54:682\u2013687","journal-title":"Pathol Int"},{"key":"1405_CR121","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00401-005-0995-7","volume":"109","author":"S Orimo","year":"2005","unstructured":"Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, Tsuchiya K, Mori F, Wakabayashi K, Takahashi H (2005) Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol 109:583\u2013588","journal-title":"Acta Neuropathol"},{"key":"1405_CR122","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00401-006-0160-y","volume":"113","author":"S Orimo","year":"2007","unstructured":"Orimo S, Kanazawa T, Nakamura A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007a) Degeneration of cardiac sympathetic nerve can occur in multiple system atrophy. Acta Neuropathol 113:81\u201386","journal-title":"Acta Neuropathol"},{"key":"1405_CR123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1750-3639.2006.00032.x","volume":"17","author":"S Orimo","year":"2007","unstructured":"Orimo S, Takahashi A, Uchihara T, Mori F, Kakita A, Wakabayashi K, Takahashi H (2007b) Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson\u2019s disease. Brain Pathol 17:24\u201330","journal-title":"Brain Pathol"},{"key":"1405_CR124","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/brain\/awm302","volume":"131","author":"S Orimo","year":"2008","unstructured":"Orimo S, Uchihara T, Nakamura A, Mori F, Kakita A, Wakabayashi K, Takahashi H (2008) Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson\u2019s disease. Brain 131:642\u2013650","journal-title":"Brain"},{"key":"1405_CR125","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/mds.21813","volume":"23","author":"SS O\u2019Sullivan","year":"2008","unstructured":"O\u2019Sullivan SS, Williams DR, Gallagher DA, Massey LA, Silveira-Moriyama L, Lees AJ (2008) Nonmotor symptoms as presenting complaints in Parkinson\u2019s disease: a clinicopathological study. Mov Disord 23:101\u2013106","journal-title":"Mov Disord"},{"key":"1405_CR126","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrn895","volume":"3","author":"EF Pace-Schott","year":"2002","unstructured":"Pace-Schott EF, Hobson JA (2002) The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci 3:591\u2013605","journal-title":"Nat Rev Neurosci"},{"key":"1405_CR127","doi-asserted-by":"crossref","unstructured":"Pan-Montojo FJ, Funk RH (2010) Oral administration of rotenone using a gavage and image analysis of alpha-synuclein inclusions in the enteric nervous system. J Vis Exp 26(44). doi: 10.3791\/2123","DOI":"10.3791\/2123"},{"key":"1405_CR128","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2047-9158-3-10","volume":"3","author":"F Pan-Montojo","year":"2014","unstructured":"Pan-Montojo F, Reichmann H (2014) Considerations on the role of environmental toxins in idiopathic Parkinson\u2019s disease pathophysiology. Transl Neurodegener 3:10","journal-title":"Transl Neurodegener"},{"key":"1405_CR129","doi-asserted-by":"crossref","first-page":"e8762","DOI":"10.1371\/journal.pone.0008762","volume":"5","author":"F Pan-Montojo","year":"2010","unstructured":"Pan-Montojo F, Anichtchik O, Dening Y, Knels L, Pursche S, Jung R, Jackson S, Gille G, Spillantini MG, Reichmann H, Funk RH (2010) Progression of Parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS One 5:e8762","journal-title":"PLoS One"},{"key":"1405_CR131","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1440-1789.2005.00644.x","volume":"25","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Pirttila T, Tervahauta M, Alafuzoff I (2005) Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. Neuropathology 25:304\u2013314","journal-title":"Neuropathology"},{"key":"1405_CR132","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00401-008-0346-6","volume":"115","author":"L Parkkinen","year":"2008","unstructured":"Parkkinen L, Pirttila T, Alafuzoff I (2008) Applicability of current staging\/categorization of alpha-synuclein pathology and their clinical relevance. Acta Neuropathol 115:399\u2013407","journal-title":"Acta Neuropathol"},{"key":"1405_CR133","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0022-510X(90)90037-N","volume":"100","author":"RH Perry","year":"1990","unstructured":"Perry RH, Irving D, Tomlinson BE (1990) Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei. J Neurol Sci 100:223\u2013233","journal-title":"J Neurol Sci"},{"key":"1405_CR134","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neuroscience.2008.02.074","volume":"153","author":"RJ Phillips","year":"2008","unstructured":"Phillips RJ, Walter GC, Wilder SL, Baronowsky EA, Powley TL (2008) Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson\u2019s disease? Neuroscience 153:733\u2013750","journal-title":"Neuroscience"},{"issue":"Suppl 1","key":"1405_CR135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","volume":"15","author":"W Poewe","year":"2008","unstructured":"Poewe W (2008) Non-motor symptoms in Parkinson\u2019s disease. Eur J Neurol 15(Suppl 1):14\u201320","journal-title":"Eur J Neurol"},{"key":"1405_CR136","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/jnnp.2009.183715","volume":"81","author":"MM Ponsen","year":"2010","unstructured":"Ponsen MM, Stoffers D, Wolters E, Booij J, Berendse HW (2010) Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 81:396\u2013399","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1405_CR137","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1002\/mds.23347","volume":"25","author":"RB Postuma","year":"2010","unstructured":"Postuma RB, Lanfranchi PA, Blais H, Gagnon JF, Montplaisir JY (2010) Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder. Mov Disord 25:2304\u20132310","journal-title":"Mov Disord"},{"key":"1405_CR138","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/ana.22282","volume":"69","author":"RB Postuma","year":"2011","unstructured":"Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 69:811\u2013818","journal-title":"Ann Neurol"},{"key":"1405_CR139","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","volume":"62","author":"RD Prediger","year":"2012","unstructured":"Prediger RD, Matheus FC, Schwarzbold ML, Lima MM, Vital MA (2012) Anxiety in Parkinson\u2019s disease: a critical review of experimental and clinical studies. Neuropharmacology 62:115\u2013124","journal-title":"Neuropharmacology"},{"issue":"Suppl 1","key":"1405_CR140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1468-1331.2008.02057.x","volume":"15","author":"A Probst","year":"2008","unstructured":"Probst A, Bloch A, Tolnay M (2008) New insights into the pathology of Parkinson\u2019s disease: does the peripheral autonomic system become central? Eur J Neurol 15(Suppl 1):1\u20134","journal-title":"Eur J Neurol"},{"key":"1405_CR141","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00702-003-0102-y","volume":"111","author":"H Przuntek","year":"2004","unstructured":"Przuntek H, Muller T, Riederer P (2004) Diagnostic staging of Parkinson\u2019s disease: conceptual aspects. J Neural Transm 111:201\u2013216","journal-title":"J Neural Transm"},{"key":"1405_CR142","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s00702-012-0775-1","volume":"119","author":"P Riederer","year":"2012","unstructured":"Riederer P, Sian-Hulsmann J (2012) The significance of neuronal lateralisation in Parkinson\u2019s disease. J Neural Transm 119:953\u2013962","journal-title":"J Neural Transm"},{"key":"1405_CR143","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","volume":"38","author":"P Riederer","year":"1976","unstructured":"Riederer P, Wuketich S (1976) Time course of nigrostriatal degeneration in parkinson\u2019s disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm 38:277\u2013301","journal-title":"J Neural Transm"},{"key":"1405_CR144","first-page":"153","volume":"14","author":"P Riederer","year":"1978","unstructured":"Riederer P, Rausch WD, Birkmayer W, Jellinger K, Danielczyk W (1978a) Dopamine-sensitive adenylate cyclase activity in the caudate nucleus and adrenal medulla in Parkinson\u2019s disease and in liver cirrhosis. J Neural Transm Suppl 14:153\u2013161","journal-title":"J Neural Transm Suppl"},{"key":"1405_CR145","first-page":"121","volume":"14","author":"P Riederer","year":"1978","unstructured":"Riederer P, Rausch WD, Birkmayer W, Jellinger K, Seemann D (1978b) CNS Modulation of adrenal tyrosine hydroxylase in Parkinson\u2019s disease and metabolic encephalopathies. J Neural Transm Suppl 14:121\u2013131","journal-title":"J Neural Transm Suppl"},{"key":"1405_CR146","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1474-4422(09)70293-5","volume":"8","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA (2009) Initial clinical manifestations of Parkinson\u2019s disease: features and pathophysiological mechanisms. Lancet Neurol 8:1128\u20131139","journal-title":"Lancet Neurol"},{"key":"1405_CR147","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/WAD.0b013e31819c5ef4","volume":"23","author":"MN Sabbagh","year":"2009","unstructured":"Sabbagh MN, Adler CH, Lahti TJ, Connor DJ, Vedders L, Peterson LK, Caviness JN, Shill HA, Sue LI, Ziabreva I, Perry E, Ballard CG, Aarsland D, Walker DG, Beach TG (2009) Parkinson disease with dementia: comparing patients with and without Alzheimer pathology. Alzheimer Dis Assoc Disord 23:295\u2013297","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"1405_CR148","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","volume":"115","author":"R Sakakibara","year":"2008","unstructured":"Sakakibara R, Uchiyama T, Yamanishi T, Shirai K, Hattori T (2008) Bladder and bowel dysfunction in Parkinson\u2019s disease. J Neural Transm 115:443\u2013460","journal-title":"J Neural Transm"},{"key":"1405_CR149","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1212\/WNL.0b013e3181c34af5","volume":"73","author":"R Savica","year":"2009","unstructured":"Savica R, Carlin JM, Grossardt BR, Bower JH, Ahlskog JE, Maraganore DM, Bharucha AE, Rocca WA (2009) Medical records documentation of constipation preceding Parkinson disease: a case-control study. Neurology 73:1752\u20131758","journal-title":"Neurology"},{"key":"1405_CR150","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1001\/archneurol.2010.135","volume":"67","author":"R Savica","year":"2010","unstructured":"Savica R, Rocca WA, Ahlskog JE (2010) When does Parkinson disease start? Arch Neurol 67:798\u2013801","journal-title":"Arch Neurol"},{"key":"1405_CR151","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","volume":"120","author":"WJ Schulz-Schaeffer","year":"2010","unstructured":"Schulz-Schaeffer WJ (2010) The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson\u2019s disease and Parkinson\u2019s disease dementia. Acta Neuropathol 120:131\u2013143","journal-title":"Acta Neuropathol"},{"key":"1405_CR152","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1097\/NEN.0b013e31818b4126","volume":"67","author":"R Sengoku","year":"2008","unstructured":"Sengoku R, Saito Y, Ikemura M, Hatsuta H, Sakiyama Y, Kanemaru K, Arai T, Sawabe M, Tanaka N, Mochizuki H, Inoue K, Murayama S (2008) Incidence and extent of Lewy body-related alpha-synucleinopathy in aging human olfactory bulb. J Neuropathol Exp Neurol 67:1072\u20131083","journal-title":"J Neuropathol Exp Neurol"},{"key":"1405_CR153","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuint.2013.06.005","volume":"63","author":"S Sharma","year":"2013","unstructured":"Sharma S, Moon CS, Khogali A, Haidous A, Chabenne A, Ojo C, Jelebinkov M, Kurdi Y, Ebadi M (2013) Biomarkers in Parkinson\u2019s disease (recent update). Neurochem Int 63:201\u2013229","journal-title":"Neurochem Int"},{"key":"1405_CR154","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1353-8020(01)00015-3","volume":"8","author":"LM Shulman","year":"2002","unstructured":"Shulman LM, Taback RL, Rabinstein AA, Weiner WJ (2002) Non-recognition of depression and other non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat Disord 8:193\u2013197","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 2","key":"1405_CR155","first-page":"S139","volume":"64","author":"A Siderowf","year":"2008","unstructured":"Siderowf A, Stern MB (2008) Premotor Parkinson\u2019s disease: clinical features, detection, and prospects for treatment. Ann Neurol 64(Suppl 2):S139\u2013S147","journal-title":"Ann Neurol"},{"key":"1405_CR156","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.neulet.2009.02.006","volume":"453","author":"L Silveira-Moriyama","year":"2009","unstructured":"Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W, Poewe W, Maier H, Lees AJ, Revesz T (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453:77\u201380","journal-title":"Neurosci Lett"},{"key":"1405_CR157","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(95)92707-7","volume":"346","author":"C Singaram","year":"1995","unstructured":"Singaram C, Ashraf W, Gaumnitz EA, Torbey C, Sengupta A, Pfeiffer R, Quigley EM (1995) Dopaminergic defect of enteric nervous system in Parkinson\u2019s disease patients with chronic constipation. Lancet 346:861\u2013864","journal-title":"Lancet"},{"key":"1405_CR158","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-005-1013-9","volume":"110","author":"M Sone","year":"2005","unstructured":"Sone M, Yoshida M, Hashizume Y, Hishikawa N, Sobue G (2005) Alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. Acta Neuropathol 110:19\u201326","journal-title":"Acta Neuropathol"},{"key":"1405_CR159","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10072-014-1879-1","volume":"35","author":"Y Song","year":"2014","unstructured":"Song Y, Gu Z, An J, Chan P (2014) Gender differences on motor and non-motor symptoms of de novo patients with early Parkinson\u2019s disease. Neurol Sci 35:1991\u20131996","journal-title":"Neurol Sci"},{"key":"1405_CR160","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1750-3639.2009.00371.x","volume":"20","author":"JA Sonnen","year":"2010","unstructured":"Sonnen JA, Postupna N, Larson EB, Crane PK, Rose SE, Montine KS, Leverenz JB, Montine TJ (2010) Pathologic correlates of dementia in individuals with Lewy body disease. Brain Pathol 20:654\u2013659","journal-title":"Brain Pathol"},{"key":"1405_CR161","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/ana.21204","volume":"62","author":"V Sossi","year":"2007","unstructured":"Sossi V, de la Fuente-Fernandez R, Schulzer M, Troiano AR, Ruth TJ, Stoessl AJ (2007) Dopamine transporter relation to dopamine turnover in Parkinson\u2019s disease: a positron emission tomography study. Ann Neurol 62:468\u2013474","journal-title":"Ann Neurol"},{"key":"1405_CR162","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M (1997) Alpha-synuclein in Lewy bodies. Nature 388:839\u2013840","journal-title":"Nature"},{"key":"1405_CR163","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40263-013-0053-2","volume":"27","author":"F Sprenger","year":"2013","unstructured":"Sprenger F, Poewe W (2013) Management of motor and non-motor symptoms in Parkinson\u2019s disease. CNS Drugs 27:259\u2013272","journal-title":"CNS Drugs"},{"key":"1405_CR164","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.expneurol.2010.05.008","volume":"224","author":"S Stemberger","year":"2010","unstructured":"Stemberger S, Poewe W, Wenning GK, Stefanova N (2010) Targeted overexpression of human alpha-synuclein in oligodendroglia induces lesions linked to MSA-like progressive autonomic failure. Exp Neurol 224:459\u2013464","journal-title":"Exp Neurol"},{"key":"1405_CR165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/brain\/awh322","volume":"128","author":"K Stiasny-Kolster","year":"2005","unstructured":"Stiasny-Kolster K, Doerr Y, Moller JC, Hoffken H, Behr TM, Oertel WH, Mayer G (2005) Combination of \u2018idiopathic\u2019 REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128:126\u2013137","journal-title":"Brain"},{"key":"1405_CR166","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/mds.23290","volume":"25","author":"HY Sung","year":"2010","unstructured":"Sung HY, Kim JS, Lee KS, Kim YI, Song IU, Chung SW, Yang DW, Cho YK, Park JM, Lee IS, Kim SW, Chung IS, Choi MG (2010) The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson\u2019s disease. Mov Disord 25:2361\u20132368","journal-title":"Mov Disord"},{"key":"1405_CR167","first-page":"558","volume":"61","author":"N Tachibana","year":"2009","unstructured":"Tachibana N (2009) Historical overview of REM sleep behavior disorder in relation to its pathophysiology. Brain Nerve 61:558\u2013568","journal-title":"Brain Nerve"},{"key":"1405_CR168","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.neuropharm.2011.01.006","volume":"61","author":"SK Tan","year":"2011","unstructured":"Tan SK, Hartung H, Sharp T, Temel Y (2011) Serotonin-dependent depression in Parkinson\u2019s disease: a role for the subthalamic nucleus? Neuropharmacology 61:387\u2013399","journal-title":"Neuropharmacology"},{"key":"1405_CR169","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1523\/JNEUROSCI.1495-09.2009","volume":"29","author":"TN Taylor","year":"2009","unstructured":"Taylor TN, Caudle WM, Shepherd KR, Noorian A, Jackson CR, Iuvone PM, Weinshenker D, Greene JG, Miller GW (2009) Nonmotor symptoms of Parkinson\u2019s disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci 29:8103\u20138113","journal-title":"J Neurosci"},{"key":"1405_CR170","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.neuroscience.2008.02.033","volume":"153","author":"YM Tian","year":"2008","unstructured":"Tian YM, Chen X, Luo DZ, Zhang XH, Xue H, Zheng LF, Yang N, Wang XM, Zhu JX (2008) Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson\u2019s disease. Neuroscience 153:634\u2013644","journal-title":"Neuroscience"},{"key":"1405_CR171","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1212\/WNL.0b013e318198db11","volume":"72","author":"E Tolosa","year":"2009","unstructured":"Tolosa E, Gaig C, Santamaria J, Compta Y (2009) Diagnosis and the premotor phase of Parkinson disease. Neurology 72:S12\u2013S20","journal-title":"Neurology"},{"key":"1405_CR172","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/B978-1-4160-6641-5.00014-3","volume-title":"Movement disorders 4","author":"E Tolosa","year":"2010","unstructured":"Tolosa E, Santamaria J, Gaig C, Compta Y (2010) Nonmotor aspects of Parkinson\u2019s disease. In: Schapira AHV, Lang AET, Fahn S (eds) Movement disorders 4. Saunders-Elsevier, Philadelphia, pp 229\u2013251"},{"key":"1405_CR173","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","volume":"181","author":"MV Ugrumov","year":"2011","unstructured":"Ugrumov MV, Khaindrava VG, Kozina EA, Kucheryanu VG, Bocharov EV, Kryzhanovsky GN, Kudrin VS, Narkevich VB, Klodt PM, Rayevsky KS, Pronina TS (2011) Modeling of presymptomatic and symptomatic stages of parkinsonism in mice. Neuroscience 181:175\u2013188","journal-title":"Neuroscience"},{"key":"1405_CR174","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/mds.23346","volume":"26","author":"SM Rooden van","year":"2011","unstructured":"van Rooden SM, Colas F, Martinez-Martin P, Visser M, Verbaan D, Marinus J, Chaudhuri RK, Kok JN, van Hilten JJ (2011) Clinical subtypes of Parkinson\u2019s disease. Mov Disord 26:51\u201358","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"1405_CR175","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000113469","volume":"38","author":"K Wakabayashi","year":"1997","unstructured":"Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson\u2019s disease. Eur Neurol 38(Suppl 2):2\u20137","journal-title":"Eur Neurol"},{"key":"1405_CR176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-010-0706-x","volume":"120","author":"K Wakabayashi","year":"2010","unstructured":"Wakabayashi K, Mori F, Tanji K, Orimo S, Takahashi H (2010) Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathol 120:1\u201312","journal-title":"Acta Neuropathol"},{"key":"1405_CR177","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s00401-003-0750-x","volume":"106","author":"Y Wakisaka","year":"2003","unstructured":"Wakisaka Y, Furuta A, Tanizaki Y, Kiyohara Y, Iida M, Iwaki T (2003) Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study. Acta Neuropathol 106:374\u2013382","journal-title":"Acta Neuropathol"},{"key":"1405_CR178","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/WNR.0b013e3282ffda5e","volume":"19","author":"L Wang","year":"2008","unstructured":"Wang L, Fleming SM, Chesselet MF, Tache Y (2008) Abnormal colonic motility in mice overexpressing human wild-type alpha-synuclein. NeuroReport 19:873\u2013876","journal-title":"NeuroReport"},{"key":"1405_CR179","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/B978-1-4160-6641-5.00013-1","volume-title":"Movement disorders 4","author":"D Weintraub","year":"2010","unstructured":"Weintraub D (2010) Psychiatric issues in Parkinson\u2019s disease. In: Schapira AHV, Lang AET, Fahn S (eds) Movement disorders 4. Saunders-Elsevier, Philadelphia, pp 213\u2013228"},{"key":"1405_CR180","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/mds.22464","volume":"24","author":"M Witt","year":"2009","unstructured":"Witt M, Bormann K, Gudziol V, Pehlke K, Barth K, Minovi A, Hahner A, Reichmann H, Hummel T (2009) Biopsies of olfactory epithelium in patients with Parkinson\u2019s disease. Mov Disord 24:906\u2013914","journal-title":"Mov Disord"},{"key":"1405_CR181","doi-asserted-by":"crossref","unstructured":"Wolters E, Braak H (2006) Parkinson\u2019s disease: premotor clinico-pathological correlations. J Neural Transm Suppl 309\u2013319","DOI":"10.1007\/978-3-211-45295-0_47"},{"key":"1405_CR182","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1586\/14737175.8.5.781","volume":"8","author":"PB Wood","year":"2008","unstructured":"Wood PB (2008) Role of central dopamine in pain and analgesia. Expert Rev Neurother 8:781\u2013797","journal-title":"Expert Rev Neurother"},{"key":"1405_CR183","first-page":"1042","volume":"2","author":"A Yoritaka","year":"2014","unstructured":"Yoritaka A, Shimo Y, Takanashi M, Fukae J, Hatano T, Nakahara T, Miyamato N, Urabe T, Hattori N (2014) Motor and non-motor symptoms of 1453 patients with Parkinson\u2019s disease: any relationship with the cumulative doses of anti-parkinsonian medications? J Neurol Disord Stroke 2:1042","journal-title":"J Neurol Disord Stroke"},{"key":"1405_CR184","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1212\/01.wnl.0000306697.48738.b6","volume":"70","author":"J Zaccai","year":"2008","unstructured":"Zaccai J, Brayne C, McKeith I, Matthews F, Ince PG (2008) Patterns and stages of alpha-synucleinopathy: relevance in a population-based cohort. Neurology 70:1042\u20131048","journal-title":"Neurology"},{"key":"1405_CR185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1620\/tjem.232.129","volume":"232","author":"H Zhang","year":"2014","unstructured":"Zhang H, Gu Z, An J, Wang C, Chan P (2014) Non-motor symptoms in treated and untreated Chinese patients with early Parkinson\u2019s disease. Tohoku J Exp Med 232:129\u2013136","journal-title":"Tohoku J Exp Med"},{"key":"1405_CR186","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2011.09.006","volume":"1420","author":"LF Zheng","year":"2011","unstructured":"Zheng LF, Wang ZY, Li XF, Song J, Hong F, Lian H, Wang Q, Feng XY, Tang YY, Zhang Y, Zhu JX (2011) Reduced expression of choline acetyltransferase in vagal motoneurons and gastric motor dysfunction in a 6-OHDA rat model of Parkinson\u2019s disease. Brain Res 1420:59\u201367","journal-title":"Brain Res"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1405-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-015-1405-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1405-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T14:32:19Z","timestamp":1691677939000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-015-1405-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":185,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1405"],"URL":"https:\/\/doi.org\/10.1007\/s00702-015-1405-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]}}}